Can-Fite BioPharma Ltd.
CANF
$1.20
-$0.03-2.44%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.88M | -5.92M | -- | -- | -- |
| Total Depreciation and Amortization | 7.00K | 4.00K | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 503.00K | 436.50K | -- | -- | -- |
| Change in Net Operating Assets | -267.00K | -358.50K | -- | -- | -- |
| Cash from Operations | -7.64M | -5.84M | -- | -- | -- |
| Capital Expenditure | -5.00K | -4.50K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.50M | 3.00M | -- | -- | -- |
| Cash from Investing | 1.50M | 3.00M | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.22M | 3.61M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -512.00K | -256.00K | -- | -- | -- |
| Cash from Financing | 6.71M | 3.36M | -- | -- | -- |
| Foreign Exchange rate Adjustments | -22.00K | -20.50K | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 547.00K | 494.00K | -- | -- | -- |